Paris - Delayed Quote • EUR
Valbiotis SA (ALVAL.PA)
At close: April 26 at 5:35 PM GMT+2
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Sebastien Peltier HDR, Ph.D. | Co-Founder, Member of the Management Board & CEO | 318k | -- | 1978 |
| Mr. Sebastien Bessy | COO & Member of the Management Board | 213k | -- | -- |
| Mr. Pascal Sirvent Ph.D. | CSO & Member of the Management Board | 241k | -- | -- |
| Ms. Murielle Cazaubiel | CMO & Member of the Management Board | 205k | -- | -- |
| Mr. Stanislas Sordet | CFO & Member of Management Board | -- | -- | -- |
| Ms. Charlotte Jezequel | CPO & Member of Management Board | -- | -- | -- |
| Dr. Josep Infesta | Head of Global Business Development | -- | -- | -- |
Valbiotis SA
rue Paul Vatine
12th Floor ZI des Quatre Chevaliers
Périgny, 17180
France
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 48
Description
Valbiotis SA engages in the research and development of health nutrition products to prevent and control metabolic and cardiovascular diseases in France. The company develops TOTUM-63 for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II/III clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with MASLD. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Corporate Governance
Valbiotis SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Apr 29, 2024
Valbiotis SA Earnings Call
Related Tickers
ALINT.PA IntegraGen SA
0.5900
-1.67%
ADOC.PA Adocia SA
8.43
+4.46%
ALSEN.PA Sensorion SA
0.7060
-0.56%
ALCOX.PA Nicox S.A.
0.3740
-0.27%
OSE.PA OSE Immunotherapeutics SA
5.56
-0.71%
NANO.PA Nanobiotix S.A.
5.45
+0.93%
GLMD Galmed Pharmaceuticals Ltd.
0.3916
+0.90%
ORMP Oramed Pharmaceuticals Inc.
2.4600
+6.96%